glp 1 drugs and menopause GLP-1 Agonists in Perimenopause: Unique Risks Potential Opportunities Postmenopausal women on the GLP-1

Glucagon-like peptide 1 agonists, also known as GLP-1s, are a type of medicine used to treat diabetes and can also help with weight loss, according to the Mayo Clinic

These same states report obesity rates near or above 40%, among the highest in the country

This resulted in a shortage of the medication to dispense to diabetic patients

Ding L, Huwyler F, Long F, Yang W, Binz J, Wernle K, et al

Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction

doi: 10.1016/j.pharmthera.2015.08.004